United Therapeutics Corporation v. Liquidia Technologies, Inc.
| United Therapeutics Corporation |
| Liquidia Technologies, Inc. |
| 1:2020cv00755 |
| June 4, 2020 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on April 17, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 20
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to the Magistrate Judge for discovery. Joinder of Parties due by 6/4/2021. Amended Pleadings due by 6/4/2021. Fact Discovery completed by 9/17/2021. Dispositive Motions due by 11/2/2021. Joint Claim Construction Brief due by 4/30/2021. A Markman Hearing is set for 5/24/2021, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 3/4/2022, at 9:00 AM in Courtroom 6A. A 3 day Bench Trial is set for 3/28/2022, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 7/31/2020. (nms)
|
|
Filing 19
PROPOSED Scheduling Order, by United Therapeutics Corporation. (Attachments: #1 Letter)(Blumenfeld, Jack) Modified on 7/31/2020 (nms).
|
|
Minute Entry for proceedings held before Judge Richard G. Andrews - Rule 16(b) Telephone Conference held on 7/30/2020. Counsel for Plaintiff: J. Blumenfeld. Counsel for Defendant: K. Keller. (Court Reporter Heather Triozzi.) (lak)
|
|
Filing 18
PROPOSED Scheduling Order, by United Therapeutics Corporation. (Attachments: #1 Letter)(Flynn, Michael) Modified on 7/28/2020 (nms).
|
|
Filing 17
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,716,793 . (Blumenfeld, Jack)
|
|
Filing 16
First AMENDED COMPLAINT against Liquidia Technologies, Inc. - filed by United Therapeutics Corporation. (Attachments: #1 Exhibits A-C)(Blumenfeld, Jack) Modified on 7/27/2020 (nms).
|
|
Filing 15
Letter to The Honorable Richard G. Andrews, from Jack Blumenfeld, regarding dial-in information for the July 30, 2020 scheduling teleconference. (Blumenfeld, Jack) Modified on 7/21/2020 (nms).
|
|
Filing 14
Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 7/30/2020, at 2:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 7/21/2020. (nms)
|
|
SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Erik B. Milch, Ivor Elrifi, Lauren Krickl and Deepa Kannappan, filed by Liquidia Technologies, Inc.. Signed by Judge Richard G. Andrews on 7/17/2020. (nms)
|
|
Pro Hac Vice Attorneys Sanya Sukduang, Jonathan R. Davies, Erik B. Milch, Ivor Elrifi, Lauren Krickl, Deepa Kannappan for Liquidia Technologies, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd)
|
|
Filing 13
MOTION for Pro Hac Vice Appearance of Attorney Sanya Sukduang, Jonathan Davies, Erik B. Milch, Ivor Elrifi, Lauren Krickl and Deepa Kannappan - filed by Liquidia Technologies, Inc.. (Keller, Karen)
|
|
Filing 12
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Liquidia Technologies, Inc.. (Keller, Karen)
|
|
Filing 11
ANSWER to #1 Complaint, and COUNTERCLAIM against United Therapeutics Corporation by Liquidia Technologies, Inc..(Keller, Karen) Modified on 7/17/2020 (nms).
|
|
SO ORDERED, re #10 STIPULATION and Order to Extend Time (*Reset Answer Deadlines: Liquidia Technologies, Inc. answer due 7/27/2020). Signed by Judge Richard G. Andrews on 6/26/2020. (nms)
|
|
Filing 10
STIPULATION and Order to Extend Time - filed by Liquidia Technologies, Inc.. (Fry, David) Modified on 6/26/2020 (nms).
|
|
Pro Hac Vice Attorney Douglas H. Carsten for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
|
|
Pro Hac Vice Attorney Joshua Mack for United Therapeutics Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal)
|
|
Filing 9
MOTION for Pro Hac Vice Appearance of Attorney William C. Jackson - filed by United Therapeutics Corporation. (Flynn, Michael)
|
|
Filing 8
MOTION for Pro Hac Vice Appearance of Attorney Douglas H. Carsten, Joshua Mack and Adam W. Burrowbridge - filed by United Therapeutics Corporation. (Flynn, Michael) Modified on 6/11/2020 (nms).
|
|
SO ORDERED, re #9 MOTION for Pro Hac Vice Appearance of Attorney William C. Jackson, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 6/11/2020. (nms)
|
|
SO ORDERED, re #8 MOTION for Pro Hac Vice Appearance of Attorney Douglas H. Carsten, Joshua Mack and Adam W. Burrowbridge, filed by United Therapeutics Corporation. Signed by Judge Richard G. Andrews on 6/11/2020. (nms)
|
|
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)
|
|
Filing 7
SUMMONS Returned Executed by United Therapeutics Corporation. Liquidia Technologies, Inc. served on 6/5/2020, answer due 6/26/2020. (Blumenfeld, Jack)
|
|
Filing 6
Summonses Issued (please complete the top portion of the form and print out for use/service). (nmg)
|
|
Filing 5
Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate BlackRock Inc. for United Therapeutics Corporation filed by United Therapeutics Corporation. (nmg)
|
|
Filing 4
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,593,066 B2; 9,604,901 B2. (nmg)
|
|
Filing 3
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 4/27/2020. Date of Expiration of Patent: 12/15/2028.Thirty Month Stay Deadline: 10/27/2022. (nmg)
|
|
Filing 2
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg)
|
|
Filing 1
COMPLAINT for PATENT INFRINGEMENT filed against Liquidia Technologies, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2974028.) - filed by United Therapeutics Corporation. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(nmg)
|
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
